3.0.0 3538 2022-02-09T03:57:00Z 2022-02-09T07:33:45Z Senate S 2020-03-19 116 ssfi00 Finance Committee Senate Standing Referred to 2020-03-19T18:30:38Z Strengthening America’s Supply Chain and National Security Act 116 6393 HR 2020-03-25 Referred to the Subcommittee on Trade. Identical bill CRS 2020-03-19 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2020-03-19 Introduced in Senate IntroReferral 10000 9 Library of Congress R000595 Sen. Rubio, Marco [R-FL] Marco Rubio R FL N W000817 Sen. Warren, Elizabeth [D-MA] Elizabeth Warren D MA A. 2020-03-19 True C001096 Sen. Cramer, Kevin [R-ND] Kevin Cramer R ND 2020-03-19 True M001169 Sen. Murphy, Christopher [D-CT] Christopher Murphy D CT S. 2020-03-19 True K000384 Sen. Kaine, Tim [D-VA] Timothy Kaine D VA M. 2020-03-19 True M000934 Sen. Moran, Jerry [R-KS] Jerry Moran R KS 2020-05-05 False R000605 Sen. Rounds, Mike [R-SD] Mike Rounds R SD 2020-05-05 False Health Administrative remedies Asia China Congressional oversight Drug, alcohol, tobacco use Government information and archives Health care coverage and access Homeland security Intelligence activities, surveillance, classified information Intergovernmental relations Manufacturing Military procurement, research, weapons development Prescription drugs Public contracts and procurement Health 00 2020-03-19 Introduced in Senate 2021-02-03T18:59:46Z Strengthening America's Supply Chain and National Security Act

This bill requires the Department of Defense (DOD) and the Department of Health and Human Services (HHS) to take specified actions concerning the importation of pharmaceutical products from China and any other countries selected by DOD.

DOD must submit to Congress a classified report that addresses, among other issues, the percentage of pharmaceutical products used by DOD that are made by such countries and recommendations related to the domestic manufacturing capacity and the resiliency of the supply chain for such products. An unclassified summary of this report must be published on a DOD website.

A manufacturer of a pharmaceutical product that has received market approval must annually submit to HHS specified information about the product's active and inactive pharmaceutical ingredients, including the sources of such ingredients and the percentage of the aggregate amount of such ingredients from China and other countries selected by DOD. HHS shall provide such information to DOD.

In addition, the bill revises certain statutory tests used to determine the country of origin of a pharmaceutical product. Specifically, a pharmaceutical product shall be deemed to have the same country of origin as the product's active pharmaceutical ingredient (API). (A recent court case held that a drug manufactured in the United States using an API from India is considered a U.S.-made product for procurement purposes.)

]]> Strengthening America’s Supply Chain and National Security Act Display Title Strengthening America’s Supply Chain and National Security Act Short Title(s) as Introduced Strengthening America’s Supply Chain and National Security Act Introduced in Senate IS Official Title as Introduced A bill to require the Secretary of Defense to submit to Congress a report on the reliance by the Department of Defense on imports of certain pharmaceutical products made in part or in whole in certain countries, to establish postmarket reporting requirements for pharmaceuticals, and for other purposes. Introduced in Senate IS Introduced in Senate 2020-03-19T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s3538is/xml/BILLS-116s3538is.xml 2020-03-19 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.